Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis and infections.
Temperature dependence of water diffusion pools in brain white matter.
Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study.
Suppression of IL-10 production by calcitriol in patients with multiple sclerosis.
Age-Dependent Decline of Nogo-A Protein in the Mouse Cerebrum.
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.
An exploratory study of decision making by informal caregivers of individuals with multiple sclerosis.
Functional Homotopic Changes in Multiple Sclerosis with Resting-State Functional MR Imaging.
The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis.
S1P and the birth of platelets.
[LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Accuracy of routine fat-suppressed FLAIR and diffusion-weighted images in detecting clinically evident optic neuritis.
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.
Early detection of neutralizing antibodies to interferon-beta in multiple sclerosis patients: binding antibodies predict neutralizing antibody development.
Involvement of Toso in activation of monocytes, macrophages, and granulocytes.
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis.
Month of birth, vitamin D and risk of immune mediated disease: a case control study.
Pathogenesis of Pediatric Multiple Sclerosis.
Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases.
Superior temporal gyrus thickness correlates with cognitive performance in multiple sclerosis.
Efficacy and safety of beta-interferon in Thai patients with demyelinating diseases.
Glia Maturation Factor Induces Interleukin-33 Release from Astrocytes: Implications for Neurodegenerative Diseases.
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.
Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity.

Pages